These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
Mood swings: Low B12 levels can elevate homeocysteine levels which can damage brain tissue and interfere with signals
MOTS-c Dosage Protocol: 5mg Every 5 Days for 20 Days Then 4 Months Rest Our protocol uses a fixed dose of 5mg (25 units) per injection throughout the full cycle
How will I feel after a B12 injection
Caution is advised when administering this injection to children under 18 years of age
In another aspect of the invention, one or more NNMT inhibitors (such as a cation of Formula I or IA, or otherwise disclosed herein) is contacted with a cell expressing NNMT followed by contacting said cell expressing NNMT with one or more chemical entities (e.g., nicotinamide riboside, nicotinamide mononucleotide) that increase intracellular NAD+ levels to provide muscular therapy